GSK Pharma - GlaxoSmithKline Pharmaceuticals Share Price

3,162.60-34.41 (-1.08%)
Volume: 65,839

Closed
Last Updated On: 31 Jul, 2025, 03:42 PM IST

3,162.60-34.41 (-1.08%)
Volume: 65,839

Stock Recommendations

Potential
Upside
1 Year
Target

BUY

Mean Recos by
4 Analysts

Strong Sell

Sell

Hold

Buy

Strong Buy

Unlock Potential Upside

Stock Reports Plus

/10

Stock Score

View Report

Earnings
Fundamentals
Relative Valuation
Risk
Price Momentum

No Rating (NR)

Negative

Neutral

Positive

Unlock Stock Score

GSK Pharma share price insights

View All

Board Meeting on Aug 1, 2025
Meeting Agenda: Quarterly Results. Please add to watchlist to track closely.
Zero Debt Burden
Company has no debt since last 5 years. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 15.46% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)
Buy Signal: Bulls on driving seat
50 day moving crossover appeared yesterday. Average price gain of 5.55% within 30 days of this signal in last 5 years.
GSK Pharma Share Price Update
GlaxoSmithKline Pharmaceuticals Ltd. share price moved down by -1.08% from its previous close of Rs 3,197.00. GlaxoSmithKline Pharmaceuticals Ltd. stock last traded price is 3,162.60
Share Price Value
Today/Current/Last 3,162.603,161.30
Previous Day 3,197.003,194.70

Share Price	Value
Today/Current/Last	3,162.603,161.30
Previous Day	3,197.003,194.70

InsightsGSK Pharma

Do you find these insights useful?

hate it
meh
love it

Key Metrics

PE Ratio

(x)

57.76

EPS - TTM

(₹)

54.75

MCap

(₹ Cr.)

53,576.35

Sectoral MCap Rank

PB Ratio

(x)

27.75

Div Yield

(%)

1.71

Face Value

(₹)

10.00

Beta

0.22

VWAP

(₹)

3,175.20

52W H/L

(₹)

3,515.70 / 1,921.00

GSK Pharma Share Price Returns

1 Day	-1.08%
1 Week	0.01%
1 Month	-6.66%
3 Months	6.68%
1 Year	15.82%
3 Years	124.89%
5 Years	120.04%

ET Stock ScreenersTop Score Companies

Check whether GSK Pharma belongs to analysts' top-rated companies list?

View Stock Screeners

GSK Pharma News & Analysis

View all GSK Pharma Share News & Announcements

GSK Pharma Share Recommendations

Recent Recos

BUY

Current

Mean Recos by 4 Analysts

Strong
SellSellHoldBuyStrong
Buy

Target₹2250
OrganizationICICI Securities
ADD

Target₹1300
OrganizationMotilal Oswal Financial Services
NEUTRAL

Analyst Trends

Ratings	Current	1 Week Ago	1 Month Ago	3 Months Ago
Strong Buy	1	1	1	1
Buy	1	1	1	2
Hold	1	1	1	1
Sell	1	1	1	-
Strong Sell	-	-	-	-
# Analysts	4	4	4	4

View all Stock Recommendations

GSK Pharma Financials

Insights

Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 15.46% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)

Quarterly \| Annual	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024
Total Income	1,015.05	984.49	1,045.31	850.29	959.63
Total Income Growth (%)	3.10	-5.82	22.94	-11.39	15.15
Total Expenses	655.90	676.30	701.23	600.52	688.24
Total Expenses Growth (%)	-3.02	-3.56	16.77	-12.75	-10.34
EBIT	359.15	308.19	344.08	249.77	271.39
EBIT Growth (%)	16.54	-10.43	37.76	-7.97	312.76
Profit after Tax (PAT)	262.87	229.88	252.50	182.33	194.48
PAT Growth (%)	14.35	-8.96	38.49	-6.25	325.37
EBIT Margin (%)	35.38	31.30	32.92	29.37	28.28
Net Profit Margin (%)	25.90	23.35	24.16	21.44	20.27
Basic EPS (₹)	15.52	13.57	14.91	10.76	11.37

Quarterly \| Annual	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024
Total Income	1,005.54	981.42	1,032.24	846.85	940.74
Total Income Growth (%)	2.46	-4.92	21.89	-9.98	12.89
Total Expenses	650.06	674.98	693.27	597.99	671.26
Total Expenses Growth (%)	-3.69	-2.64	15.93	-10.92	-12.58
EBIT	355.48	306.44	338.97	248.86	269.48
EBIT Growth (%)	16.00	-9.60	36.21	-7.65	311.86
Profit after Tax (PAT)	260.14	228.58	248.69	181.65	193.08
PAT Growth (%)	13.81	-8.09	36.91	-5.92	324.44
EBIT Margin (%)	35.35	31.22	32.84	29.39	28.65
Net Profit Margin (%)	25.87	23.29	24.09	21.45	20.52
Basic EPS (₹)	15.35	13.49	14.68	10.72	11.29

Quarterly \| Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	3,895.14	3,576.30	3,352.38	3,353.80	3,036.18
Total Revenue Growth (%)	8.92	6.68	-0.04	10.46	-8.09
Total Expenses	2,639.95	2,616.50	2,515.02	2,586.33	2,409.60
Total Expenses Growth (%)	0.90	4.03	-2.76	7.33	-9.28
Profit after Tax (PAT)	930.24	594.13	616.72	1,694.72	358.15
PAT Growth (%)	56.57	-3.66	-63.61	373.19	284.26
Operating Profit Margin (%)	33.51	27.84	25.80	23.47	21.53
Net Profit Margin (%)	24.81	17.20	18.96	51.69	12.24
Basic EPS (₹)	54.52	41.14	36.08	99.29	31.35

Quarterly \| Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	3,866.05	3,530.73	3,317.86	3,293.72	3,030.66
Total Revenue Growth (%)	9.50	6.42	0.73	8.68	-8.22
Total Expenses	2,622.31	2,578.08	2,484.50	2,531.86	2,404.84
Total Expenses Growth (%)	1.72	3.77	-1.87	5.28	-9.43
Profit after Tax (PAT)	919.05	584.69	607.75	1,690.53	357.57
PAT Growth (%)	57.19	-3.79	-64.05	372.78	224.91
Operating Profit Margin (%)	33.43	28.01	25.96	23.74	21.54
Net Profit Margin (%)	24.68	17.16	18.89	52.54	12.24
Basic EPS (₹)	54.01	40.83	35.90	99.05	31.32

All figures in Rs Cr, unless mentioned otherwise

View Details

Insights

Zero Debt Burden
Company has no debt since last 5 years. (Source: Consolidated Financials)

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Assets	4,108.07	3,556.62	3,326.58	4,633.28	3,114.65
Total Assets Growth (%)	15.50	6.91	-28.20	48.76	-0.59
Total Liabilities	2,156.75	1,778.98	1,585.31	1,970.32	1,636.39
Total Liabilities Growth (%)	21.24	12.22	-19.54	20.41	24.66
Total Equity	1,951.31	1,777.64	1,741.27	2,662.96	1,478.26
Total Equity Growth (%)	9.77	2.09	-34.61	80.14	-18.80
Current Ratio (x)	1.79	1.84	1.88	2.18	1.63
Total Debt to Equity (x)	0.00	0.00	0.00	0.00	0.00
Contingent Liabilities	490.50	387.14	361.80	368.97	498.50

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Assets	4,100.93	3,547.80	3,327.70	4,622.60	3,097.08
Total Assets Growth (%)	15.59	6.61	-28.01	49.26	-1.10
Total Liabilities	2,151.70	1,763.71	1,574.70	1,944.98	1,599.96
Total Liabilities Growth (%)	22.00	12.00	-19.04	21.56	23.89
Total Equity	1,949.23	1,784.09	1,753.00	2,677.62	1,497.12
Total Equity Growth (%)	9.26	1.77	-34.53	78.85	-18.64
Current Ratio (x)	1.78	1.83	1.87	2.19	1.65
Total Debt to Equity (x)	0.00	0.00	0.00	0.00	0.00
Contingent Liabilities	487.56	0.00	358.51	365.29	493.24

All figures in Rs Cr, unless mentioned otherwise

View Details

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash flow from Operating Activities	1,289.90	582.02	484.23	810.75	577.93
Net Cash used in Investing Activities	-45.80	8.71	807.85	-405.51	418.59
Net Cash flow from Financing Activities	-769.42	-561.50	-1,543.32	-524.24	-696.14
Net Cash Flow	474.68	29.23	-251.25	-119.00	300.38
Closing Cash & Cash Equivalent	538.85	64.17	34.94	286.19	405.19
Closing Cash & Cash Equivalent Growth (%)	739.70	83.66	-87.79	-29.37	286.59
Total Debt/ CFO (x)	0.00	0.00	0.00	0.00	0.00

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash flow from Operating Activities	1,280.03	578.93	487.94	819.79	594.87
Net Cash used in Investing Activities	-36.53	14.97	805.19	-419.66	407.57
Net Cash flow from Financing Activities	-769.42	-561.49	-1,544.18	-524.24	-695.56
Net Cash Flow	474.07	32.41	-251.05	-124.11	306.87
Closing Cash & Cash Equivalent	536.22	62.15	29.74	280.79	404.90
Closing Cash & Cash Equivalent Growth (%)	762.78	108.96	-89.41	-30.65	313.05
Total Debt/ CFO (x)	0.00	0.00	0.00	0.00	0.00

All figures in Rs Cr, unless mentioned otherwise

View Details

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Return on Equity (%)	47.67	33.42	35.41	63.64	24.22
Return on Capital Employed (%)	57.03	47.33	41.95	26.21	35.80
Return on Assets (%)	22.64	16.70	18.53	36.57	11.49
Interest Coverage Ratio (x)	1,007.30	573.35	499.36	419.65	200.69
Asset Turnover Ratio (x)	0.98	1.00	0.81	0.83	0.94
Price to Earnings (x)	52.63	55.56	36.50	16.64	68.49
Price to Book (x)	24.98	18.52	12.88	10.58	16.51
EV/EBITDA (x)	35.77	30.89	23.51	30.67	32.80
EBITDA Margin (%)	35.29	29.86	27.82	25.55	24.22

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Return on Equity (%)	47.14	32.77	34.66	63.13	23.88
Return on Capital Employed (%)	56.59	46.85	41.53	25.90	35.40
Return on Assets (%)	22.41	16.48	18.26	36.57	11.54
Interest Coverage Ratio (x)	998.21	569.37	497.54	418.15	200.48
Asset Turnover Ratio (x)	0.97	0.99	0.81	0.83	0.94
Price to Earnings (x)	53.19	56.50	37.04	16.67	68.49
Price to Book (x)	25.01	18.45	12.80	10.52	16.30
EV/EBITDA (x)	36.09	31.11	23.62	30.88	32.83
EBITDA Margin (%)	35.23	30.05	28.01	25.85	24.24

Financial InsightsGSK Pharma

Income (P&L)
Balance Sheet

- Employee & Interest Expense
  Company has spent less than 1% of its operating revenues towards interest expenses and 15.46% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)
- Zero Debt Burden
  Company has no debt since last 5 years. (Source: Consolidated Financials)

Do you find these insights useful?

hate it
meh
love it

GSK Pharma Share Price Forecast

Get multiple analysts’ prediction on GSK Pharma
High, low, medium predictions for Price
Upcoming predictions for Revenue
Details about company earnings
START FREE TRIAL
Get multiple analysts’ prediction on GSK Pharma
High, low, medium predictions for Price
Upcoming predictions for Revenue
Details about company earnings
START FREE TRIAL
Get multiple analysts’ prediction on GSK Pharma
High, low, medium predictions for Price
Upcoming predictions for Revenue
Details about company earnings
START FREE TRIAL

GSK Pharma Technicals

Bullish / Bearish signals for GSK Pharma basis selected technical indicators and moving average crossovers.
14 Day EMA Crossover
Bearish signal on daily chart
Appeared on:

GSK Pharma Peer Comparison

CHART
TABLE

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
GSK Pharma Stock Performance	-1.08	0.01	-6.66	6.68	15.82	124.89	120.04
Abbott India Stock Performance	-2.25	-0.51	-3.55	14.74	21.21	71.90	121.45
Pfizer Stock Performance	-1.26	-1.79	-8.51	21.00	-8.07	24.16	21.43
AstraZeneca Stock Performance	-1.65	1.79	3.12	5.82	30.55	199.73	175.28
Sanofi India Stock Performance	-0.96	-1.65	-8.58	-1.99	-11.87	-8.05	-25.01
Add More

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
GSK Pharma	57.76	27.46	47.67	57.03	22.64	5.06	33.51	24.74	54.52	1.79	0.00	0.00
Abbott India	51.69	17.27	33.41	42.09	23.90	10.08	29.61	22.06	665.62	3.39	0.00	0.00
Pfizer	30.96	26.37	33.24	22.93	27.21	-2.79	28.27	40.85	100.38	5.04	0.00	0.00
AstraZeneca	198.42	29.81	15.02	31.23	7.62	28.57	14.83	6.74	46.30	1.91	0.00	0.00
Sanofi India	33.86	15.59	48.02	52.72	25.64	-12.39	23.37	20.52	179.46	1.57	0.00	0.00
Add More

Annual Ratios (%)

Choose from Peers

Sanofi Consumer Healthcare India Ltd.
P&G Health

Choose from Stocks

See All Parameters

Peers InsightsGSK Pharma

Do you find these insights useful?

hate it
meh
love it

GSK Pharma Shareholding Pattern

Loading...
Showing GSK Pharma Shareholding as on Jun 2025
Category Jun 2025 Mar 2025 Dec 2024 Jun 2024
Promoters 75.00 75.00 75.00 75.00
Pledge 0.00 0.00 0.00 0.00
FII 4.89 4.52 4.50 4.02
DII 7.69 7.77 7.28 7.49
Mutual Funds 5.17 5.17 4.96 4.71
Others 12.42 12.71 13.21 13.49
Showing Shareholding as on Jun 2025
Category No. of Shares Percentage % Change QoQ
Promoters 12,70,54,524 75.00 % 0.00
Pledge 0 0.00 % 0.00
FII 82,76,711 4.89 % 0.37
DII 1,30,17,079 7.69 % -0.07
MF 87,52,158 5.17 % 0.00
Others 2,10,57,720 12.42 % -0.29

Category	Jun 2025	Mar 2025	Dec 2024	Jun 2024
Promoters	75.00	75.00	75.00	75.00
Pledge	0.00	0.00	0.00	0.00
FII	4.89	4.52	4.50	4.02
DII	7.69	7.77	7.28	7.49
Mutual Funds	5.17	5.17	4.96	4.71
Others	12.42	12.71	13.21	13.49

Category	No. of Shares	Percentage	% Change QoQ
Promoters	12,70,54,524	75.00 %	0.00
Pledge	0	0.00 %	0.00
FII	82,76,711	4.89 %	0.37
DII	1,30,17,079	7.69 %	-0.07
MF	87,52,158	5.17 %	0.00
Others	2,10,57,720	12.42 %	-0.29

GSK Pharma MF Ownership

SBI Midcap Direct-G
Equity: Mid Cap
4
- 474.33
  Amount Invested (in Cr.)
- 2.03848027%
  % of AUM
- -17.47
  % Change (MoM basis)
Kotak Large & Midcap Direct-G
Equity: Large & MidCap
3
- 372.69
  Amount Invested (in Cr.)
- 1.32%
  % of AUM
- 0.00
  % Change (MoM basis)
Nippon India Pharma Direct-G
Equity: Sectoral-Pharma
3
- 311.42
  Amount Invested (in Cr.)
- 3.63%
  % of AUM
- -2.60
  % Change (MoM basis)

MF Ownership as on 30 June 2025

View all Mutual Fund Schemes

GSK Pharma Corporate Actions

Meeting Date	Announced on	Purpose	Details
Aug 01, 2025	Jul 04, 2025	Board Meeting	Quarterly Results
Jun 27, 2025	May 13, 2025	AGM	-
May 13, 2025	Apr 17, 2025	Board Meeting	Audited Results & Final Dividend
Apr 30, 2025	Mar 28, 2025	POM	-
Feb 14, 2025	Jan 20, 2025	Board Meeting	Quarterly Results

Type	Dividend	Dividend per Share	Ex-Dividend Date	Announced on
Final	420%	42.0	May 30, 2025	May 13, 2025
Interim	120%	12.0	Nov 07, 2024	Oct 24, 2024
Final	320%	32.0	May 31, 2024	May 17, 2024
Final	320%	32.0	Jun 30, 2023	May 17, 2023
Special	600%	60.0	Jul 07, 2022	May 17, 2022

All Types	Ex-Date	Record Date	Announced on	Details
Bonus	Sep 11, 2018	Sep 13, 2018	Jul 24, 2018	Bonus Ratio: 1 share(s) for every 1 shares held
Bonus	Jan 02, 1995	Jan 24, 1995	Sep 28, 1995	Bonus Ratio: 1 share(s) for every 1 shares held
Rights	May 21, 1993	Jun 15, 1993	Sep 30, 1993	Rights ratio: 1 share for every 5 held at a price of Rs 65.0
Bonus	-	-	Jun 23, 1980	Bonus Ratio: 1 share(s) for every 3 shares held

About GSK Pharma

GlaxoSmithKline Pharmaceuticals Ltd., incorporated in the year 1924, is a Large Cap company (having a market cap of Rs 54,159.11 Crore) operating in Pharmaceuticals sector. GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Service Income and Other Operating Revenue for the year ending 31-Mar-2025. Show More

Executives
Auditors

RS
R S Karnad
Chairperson
BA
B Akshikar
Managing Director
JC
J Chandy
WholeTime Director & CFO
SW
S Williams
Non Executive Director
AW
A Wadhawan
Independent Director
MA
M Anand
Independent Director
PR
P R Somasundaram
Independent Director
SM
S Maheshwari
Independent Director
AN
Ajay Nadkarni
Co. Secretary & Compl. Officer
Show More
Deloitte Haskins & Sells LLP

Industry

Pharma - MNC

Key Indices Listed on

Nifty 500, BSE 500, BSE MidCap, + 22 more

Address

GSK House,Dr. Annie Besant Road,Worli,Mumbai, Maharashtra - 400030

Contact

in.investorquery@gsk.com

http://www.gsk-india.com

More Details

FAQs about GSK Pharma share

1. What's the GSK Pharma share price today?
As on 31 Jul, 2025, 03:59 PM IST GSK Pharma share price is down by 1.08% basis the previous closing price of Rs 3,150.2. GSK Pharma share price is Rs 3,162.60. Return Performance of GSK Pharma Shares:
- 1 Week: GSK Pharma share price moved up by 0.01%
- 3 Month: GSK Pharma share price moved up by 6.68%
- 6 Month: GSK Pharma share price moved up by 59.96%
2. What is the market cap of GSK Pharma?
Market Capitalization of GSK Pharma stock is Rs 53,576.35 Cr.
3. What is the PE & PB ratio of GSK Pharma?
The PE ratio of GSK Pharma stands at 58.39, while the PB ratio is 27.76.
4. What are the returns for GSK Pharma share?
Return Performance of GSK Pharma Shares:
- 1 Week: GSK Pharma share price moved up by 0.01%
- 3 Month: GSK Pharma share price moved up by 6.68%
- 6 Month: GSK Pharma share price moved up by 59.96%
5. What is GSK Pharma's 52 week high / low?
52 Week high of GSK Pharma share is Rs 3,515.70 while 52 week low is Rs 1,921.00

Trending in Markets

Top Gainers As on 03:59 PM | 31 Jul 2025

Sagility India46.62

4.23 (9.98%)

Kaynes Technology6,172.00

534.00 (9.48%)

HEG573.10

38.86 (7.28%)

Emami600.65

35.36 (6.26%)

Schneider1,002.90

47.75 (5.00%)

Top Losers As on 03:59 PM | 31 Jul 2025

Apar Industries8,907.50

-762.00 (-7.89%)

Hind Copper243.35

-15.01 (-5.81%)

Redington250.20

-15.25 (-5.75%)

Aarti Inds420.05

-25.45 (-5.72%)

Birlasoft391.50

-23.25 (-5.61%)

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.

BrowseCompanies:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

1 2 3 4 5 6 7 8 9

1 Day	-1.04%
1 Week	0.04%
1 Month	-6.66%
3 Months	6.82%
1 Year	15.68%
3 Years	124.65%
5 Years	119.88%

ETPrime

GSK Pharma - GlaxoSmithKline Pharmaceuticals Share Price

GSK Pharma share price insights

InsightsGSK Pharma

Key Metrics

Key Metrics

GSK Pharma Share Price Returns

ET Stock ScreenersTop Score Companies

GSK Pharma News & Analysis

GSK Pharma Share Recommendations

Recent Recos

Analyst Trends

GSK Pharma Financials

Insights

Insights

Financial InsightsGSK Pharma

GSK Pharma Share Price Forecast

Get multiple analysts’ prediction on GSK Pharma

Get multiple analysts’ prediction on GSK Pharma

Get multiple analysts’ prediction on GSK Pharma

GSK Pharma Technicals

GSK Pharma Peer Comparison

Ratio Performance

Peers InsightsGSK Pharma

GSK Pharma Shareholding Pattern

GSK Pharma MF Ownership

SBI Midcap Direct-G

Kotak Large & Midcap Direct-G

Nippon India Pharma Direct-G

GSK Pharma Corporate Actions

About GSK Pharma

Executives

Auditors

More Details

FAQs about GSK Pharma share

Trending in Markets

Top Gainers As on 03:59 PM | 31 Jul 2025

Top Losers As on 03:59 PM | 31 Jul 2025

GSK Pharma Quick Links

Equity Quick Links

More from Markets